For today's exceptional episode, I traveled to Berlin to find out how the visionary Dr. Ingmar Schuster is using A.I. to transform biology and chemistry research, thereby helping solve the world's most pressing problems, from cancer to climate change.

Ingmar:

• Is CEO and co-founder of Exazyme, a German biotech startup that aims to make chemical design as easy as using an app.

• Previously he worked as a research scientist and senior applied scientist at Zalando, the gigantic European e-retailer.

• Completed his PhD in Computer Science at Leipzig University and postdocs at the Université Paris Dauphine and the Freie Universität Berlin, throughout which he focused on using Bayesian and Monte Carlo approaches to model natural language and time series.

Today’s episode is on the technical side so may appeal primarily to hands-on practitioners such as data scientists and machine learning engineers.

In this episode, Ingmar details:

• What kernel methods are and how he uses them at Exazyme to dramatically speed the design of synthetic biological catalysts and antibodies for pharmaceutical firms and chemical producers, with applications including fixing carbon dioxide more effectively than plants and allowing our own immune system to detect and destroy cancer.

• When “shallow” machine learning approaches are more valuable than deep learning approaches.

• Why the benefits of A.I. research far outweigh the risks.

• What it takes to become a deep-tech entrepreneur like him.

The SuperDataScience podcast is available on all major podcasting platforms, YouTube, and at SuperDataScience.com.